Aquestive Therapeutics Inc (AQST)

Operating Cash Flow Growth

-19.29%

Quarterly · Period ending:

AQST logo

AQST Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-19.29%
AQST Quarterly Cash from Operations YoY % (-79.91% → -19.29%)
High-resolution chart · PNG

AQST operating cash flow growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Aquestive Therapeutics Inc Operating Cash Flow Growth — Quarterly
Period endingOperating Cash Flow Growth
-19.2949%
36.7265%
-30.5132%
-6.4731%
-12.9603%
-125.3467%
-31.3031%
-406.1781%
11.395%
-217.7858%
-158.5129%
-183.5529%
-20.4968%
160.8756%
204.7761%
130.9873%
-273.6902%
-2.7311%
40.3419%
-9.0461%
82.4347%
-3.3732%
-27.773%
43.7893%
41.7628%
22.8676%
-276.0669%
-28.8802%
-3,459.2955%
-2,352.2293%
62.0462%
-173.4306%
108.1085%
-79.913%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.